HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences

scientific article published on 12 June 2014

HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIU333
P698PubMed publication ID24924164
P5875ResearchGate publication ID263100044

P50authorWilliam M SwitzerQ61472738
Silvina MasciotraQ112056633
P2093author name stringJeffrey A Johnson
S Michele Owen
Jin-fen Li
Jonathan T Lipscomb
P2860cites workTransmission, acute HIV-1 infection and the quest for strategies to prevent infectionQ22251056
Gender differences in HIV-1 diversity at time of infectionQ24706473
Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutationsQ28469253
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacyQ28473296
Wide variation in the multiplicity of HIV-1 infection among injection drug usersQ33877419
Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groupsQ33934355
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infectionQ34228730
Transmission of equine influenza virus during an outbreak is characterized by frequent mixed infections and loose transmission bottlenecks.Q34544417
Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infectionsQ34764036
A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutationQ34976902
Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with TruvadaQ35140323
Contribution of intra- and interhost dynamics to norovirus evolutionQ35826200
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencingQ36540055
Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United StatesQ36673152
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infectionQ37273158
Evolutionary analysis of the dynamics of viral infectious diseaseQ37535485
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Q37568289
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infectionQ42255433
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsQ45784529
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectHIV transmissionQ49029021
P1104number of pages11
P304page(s)1827-1837
P577publication date2014-06-12
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleHIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences
P478volume210

Reverse relations

cites work (P2860)
Q95371858Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction
Q39289633Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
Q58546281LOW-BIAS RNA SEQUENCING OF THE HIV-2 GENOME FROM BLOOD PLASMA
Q36438778Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation
Q28545183Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients

Search more.